Aller au contenu principal

Appel à projets GILEAD "COvid-19 unMet MedIcal needs and associated research exTension"

p2 |

p2
14 July 2020, modified on 12 December 2024

DL 03/08/2020 - Closing date of COMMIT™ (COvid-19 unMet MedIcal needs and associated research exTension) COVID-19 RFP program.

 

The COMMIT™ program will support well defined individual projects of no more than $250,000 USD or equivalent sum. Projects that are more than $250,000 will require approval by Gilead prior to submission.​

 

Gilead will not consider proposals that request COVID-19 screening costs (including test kits) or proposals that requests remdesivir or other study drug.

 

Gilead will consider support for research proposals that meet one of the following criteria:

  • Expand data on clinical course and outcome in vulnerable populations:
    • Immune suppressed, specifically- HIV, cancer chronic inflammatory conditions (i.e., RA or IBD), and chronic liver disease, pre-existing pulmonary disease
    • Residents of long-term care facilities/nursing homes, and older adults
    • At risk for healthcare disparities
  • Long-term sequelae (i.e., pulmonary fibrosis, neurologic, cardiac, quality of life)
  • Real world safety and effectiveness of remdesivir used alone or with other agents (JAK inhibitors, IL-6 inhibitors, convalescent plasma and ACE inhibitors and ARBs):
    • Viral kinetics and clinical outcomes
    • Based on duration of treatment (e.g., 5 vs 10 days, shorter courses)
    • Use in early (non-severe) disease
    • Course completion in alternative or alternative treatment pathways

Letters of intent (LOI)
They should adhere to the following:

  • Proposed budget is ≤ $250,000 USD or equivalent sum; Gilead approval will be required prior to submission for proposals with a budget of > $250,000
    • Including overhead costs and applicable taxes
    • Proposed overhead costs are ≤ 30% of the total budget
  • The proposed study design will not take longer than 6 to 9 months to complete
  • Funding request for sole purpose of screening costs is not acceptable for COMMIT
  • Funding for or contribution of study drug is not acceptable for COMMIT
  • No more than one sponsor for contract negotiations and/or Institutional Review Board (IRB) or Ethics Committee (EC) review
  • Entered into the provided LOI form
  • Research plan should not exceed 1,000 word limit

Detailed information

Submission
LOI, curriculum vitae, and overhead policy forms should be submitted here.

Deadline: 03/08/2020

Website

Contact UCLouvain
Please, feel free to contact Ms Mahdia Abdelouahab (ADRE/RINT - Phone: +32 (0)10 47.24.80) who will support you in reviewing eligibility conditions and preparing legal documents.